Matthew B. Wiener, PharmD

Dr. Wiener is founder and president of Pharmatech, Inc., a research management organization with a focus on oncology clinical trials. He developed the Just-In-Time (JIT) enrollment methodology for cancer clinical trials which focuses on the efficient treatment of patients which results in a shorter time frame for completion of clinical trials. He earned his PharmD. at the Columbia University.